Sex Analysis of Lipid Profile in Diabetes Patients with and without Over Weight in Tikrit City/Iraq

Asmaa Sultan Mohammed; Maan Hasan Salih; Maksood Adil Mahmoud Al-Doori

doi:10.55544/jrasb.1.3.16

Authors

Asmaa Sultan Mohammed Department of Biology, College of Science, Tikrit University, Tikrit, IRAQ.
Maan Hasan Salih Department of Biology, College of Science, Tikrit University, Tikrit, IRAQ.
Maksood Adil Mahmoud Al-Doori Department of Prostheses, Al-Dour Technical Institute, Northern Technical University, Saladin, IRAQ.

DOI:

https://doi.org/10.55544/jrasb.1.3.16

Keywords:

Diabetes, Overweight, Lipids profile, Sex difference

Abstract

Background: The overweight is one of the main reasons for the development of diabetes, so the lipid profile is different between the diabetes and the healthy people. In addition, there is a variation between the lipids profile according to sex difference in the diabetes patients. The main goal of the current study was to assessment the relationship between lipid profiles-based sex difference of diabetes patients (with and without overweight) and control group.

Methodology: In this study, the glucose level and lipid profiles were determined for one hundred and forty volunteers, thirty-nine of them were healthy as a control group (25 females and 16 males), and one hundred and two had diabetes, 50 diabetes with overweight (25 females and 25 males) and 52 diabetes without overweight (27 females and 25 males).

Results: Concerning the results of glucose level, the results of the current study showed significant differences between males and females in HbA1c test of control group (P=0.024) and in PPG test of Diabetes without overweight group (P=0.033). On other hands, our results found variation between men and women in other groups but not reach to significant differences. While the results of lipids profile showed significant differences between males and females in HDL_C test of diabetes without overweight group (P=0.0246) and in LDL_C test of control group (P=0.02). At the same time, our results recorded variation between men and women in other groups but not reach to significant differences.

Conclusions: The research presents important results on the differences between sex and its content of lipid profiles in diabetic patients, although some differences did not reach at significant level, but they showed clear sex differences.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Dilworth, L., Facey, A., & Omoruyi, F. (2021). Diabetes mellitus and its metabolic complications: the role of adipose tissues. International Journal of Molecular Sciences, 22(14), 7644.Wilcox, G. (2005). Insulin and insulin resistance. Clinical biochemist reviews, 26(2), 19.

Chatterjee, S., Khunti, K., & Davies, M. J. (2017). Type 2 diabetes. The lancet, 389(10085), 2239-2251.

Sun, H., Saeedi, P., Karuranga, S., Pinkepank, M., Ogurtsova, K., Duncan, B. B., & Magliano, D. J. (2022). IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes research and clinical practice, 183, 109119.

Ozougwu, J. C., Obimba, K. C., Belonwu, C. D., & Unakalamba, C. B. (2013). The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. J Physiol Pathophysiol, 4(4), 46-57.

International Diabetes Federation. Diabetes prevalence (% of population ages 20–79). Available at: http://data.worldbank.org/indicator/SH.STA.DIAB.ZS?order=wbapi_data_value_2015+wbapi_data_value+wbapi_data_value-first&sort=desc.

Shah, R. (2015). Assessing the risk of diabetes. BMJ: British Medical Journal, 351, h4525.

Medical Research Council. Diabetes: Facts and Stats. Available online: https://www.mrc.ac.uk/documents/pdf/diabetes-ukfacts-and-stats-june-2015 (accessed on 23 April 2021.

Bhowmik, B., Siddiquee, T., Mujumder, A., Afsana, F., Ahmed, T., Mdala, I. A., & Omsland, T. K. (2018). Serum lipid profile and its association with diabetes and prediabetes in a rural Bangladeshi population. International journal of environmental research and public health, 15(9), 1944.

Sugden, M., & Holness, M. (2011). Pathophysiology of diabetic dyslipidemia: implications for atherogenesis and treatment. Clinical Lipidology, 6(4), 401-411.

Wu, L., & Parhofer, K. G. (2014). Diabetic dyslipidemia. Metabolism, 63(12), 1469-1479.

Gerber, P. A., Spirk, D., Brändle, M., Thoenes, M., Lehmann, R., & Keller, U. (2011). Regional differences of glycaemic control in patients with type 2 diabetes mellitus in Switzerland: a national cross-sectional survey. Swiss Medical Weekly, 141, w13218.

Joshi, S. R., Anjana, R. M., Deepa, M., Pradeepa, R., Bhansali, A., Dhandania, V. K., & ICMR–INDIAB Collaborative Study Group. (2014). Prevalence of dyslipidemia in urban and rural India: the ICMR–INDIAB study. PloS one, 9(5), e96808.

Metelskaya, V. A., Shalnova, S. A., Yarovaya, E. B., Kutsenko, V. A., Boytsov, S. A., Shlyakhto, E. V., & Drapkina, O. M. (2022). Lipoprotein Profile in Populations from Regions of the Russian Federation: ESSE-RF Study. International journal of environmental research and public health, 19(2), 931.

Ordovas, J. M. (2007). Gender, a significant factor in the cross talk between genes, environment, and health. Gender medicine, 4, S111-S122.

Tracey, M. L., McHugh, S. M., Buckley, C. M., Canavan, R. J., Fitzgerald, A. P., & Kearney, P. M. (2016). The prevalence of Type 2 diabetes and related complications in a nationally representative sample of adults aged 50 and over in the Republic of Ireland. Diabetic Medicine, 33(4), 441-445.

Jia, W. P., Pang, C., Chen, L., Bao, Y. Q., Lu, J. X., Lu, H. J., ... & Xiang, K. S. (2007). Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities. Diabetologia, 50(2), 286-292.

Nordström*, A., Hadrévi, J., Olsson, T., Franks, P. W., & Nordström, P. (2016). Higher prevalence of type 2 diabetes in men than in women is associated with differences in visceral fat mass. The Journal of Clinical Endocrinology & Metabolism, 101(10), 3740-3746.

Centers for Disease Control and Prevention. (2017). National diabetes statistics report, 2017 Atlanta. GA: Centers for Disease Control and Prevention, US Dept of Health and Human Services.

Hilawe, E. H., Yatsuya, H., Kawaguchi, L., & Aoyama, A. (2013). Differences by sex in the prevalence of diabetes mellitus, impaired fasting glycaemia and impaired glucose tolerance in sub-Saharan Africa: a systematic review and meta-analysis. Bulletin of the World Health Organization, 91, 671-682D.

Faerch, K., Borch-Johnsen, K., Vaag, A., Jørgensen, T., & Witte, D. R. (2010). Sex differences in glucose levels: a consequence of physiology or methodological convenience? The Inter99 study. Diabetologia, 53(5), 858-865.

Mauvais-Jarvis, F. (2018). Gender differences in glucose homeostasis and diabetes. Physiology & behavior, 187, 20-23.

Tramunt, B., Smati, S., Grandgeorge, N., Lenfant, F., Arnal, J. F., Montagner, A., & Gourdy, P. (2020). Sex differences in metabolic regulation and diabetes susceptibility. Diabetologia, 63(3), 453-461.

Anderwald, C., Gastaldelli, A., Tura, A., Krebs, M., Promintzer-Schifferl, M., Kautzky-Willer, A., & Bischof, M. G. (2011). Mechanism and effects of glucose absorption during an oral glucose tolerance test among females and males. The Journal of Clinical Endocrinology & Metabolism, 96(2), 515-524.

Færch, K., Pacini, G., Nolan, J. J., Hansen, T., Tura, A., & Vistisen, D. (2013). Impact of glucose tolerance status, sex, and body size on glucose absorption patterns during OGTTs. Diabetes care, 36(11), 3691-3697.

Schiebinger, L., Klinge, I., Sánchez de Madariaga, I., Paik, H. Y., Schraudner, M., & Stefanick, M. (2011). Gendered innovations in science, health & medicine, engineering, and environment. Available at genderedinnovations stanford edu/what-is-gendered-innovations html Accessed January, 21, 2015.

Snell, D. M., & Turner, J. M. (2018). Sex chromosome effects on male–female differences in mammals. Current Biology, 28(22), R1313-R1324.

Kim, J., Shin, S. J., Kim, Y. S., & Kang, H. T. (2021). Positive association between the ratio of triglycerides to high-density lipoprotein cholesterol and diabetes incidence in Korean adults. Cardiovascular Diabetology, 20(1), 1-10.

Nakhjavani, M., Esteghamati, A. R., & Heshmat, F. E. A. (2006). Dyslipidemia in type 2 diabetes mellitus: more atherogenic lipid profile in women. Acta Medica Iranica, 111-118.

Low, S., Khoo, K. C. J., Irwan, B., Sum, C. F., Subramaniam, T., Lim, S. C., & Wong, T. K. M. (2018). The role of triglyceride glucose index in development of Type 2 diabetes mellitus. Diabetes research and clinical practice, 143, 43-49.

Rhee, E. J., Han, K., Ko, S. H., Ko, K. S., & Lee, W. Y. (2017). Increased risk for diabetes development in subjects with large variation in total cholesterol levels in 2,827,950 Koreans: a nationwide population-based study. PloS one, 12(5), e0176615.

Lau, V. W., Journoud, M., & Jones, P. J. (2005). Plant sterols are efficacious in lowering plasma LDL and non-HDL cholesterol in hypercholesterolemic type 2 diabetic and nondiabetic persons. The American Journal of Clinical Nutrition, 81(6), 1351-1358.

Mannion, J., Nagle, N., Wassell, G., & Brassill, M. J. (2021). Lipid profile analyses of patients with and without type-2 diabetes in a cardiac rehabilitation population. European Journal of Preventive Cardiology, 28(Supplement_1), zwab061-286.

Tabazzum, R., Mia, A. R., Haq, R. U., & Epsi, E. Z. (2016). Study on Glycaemic Status and Lipid Profile in Type 2 Diabetic Patients Attending Mymensingh Medical College Hospital, Mymensingh. Mymensingh Medical Journal: MMJ, 25(3), 438-444.

National Institutes of Health. (2018). Cholesterol Levels: What You Need to Know. Medline Plus Website.

Haase, C. L., Tybjærg-Hansen, A., Nordestgaard, B. G., & Frikke-Schmidt, R. (2015). HDL cholesterol and risk of type 2 diabetes: a Mendelian randomization study. Diabetes, 64(9), 3328-3333.

Hanai, K., Babazono, T., Yoshida, N., Nyumura, I., Toya, K., Hayashi, T., & Iwamoto, Y. (2012). Gender differences in the association between HDL cholesterol and the progression of diabetic kidney disease in type 2 diabetic patients. Nephrology Dialysis Transplantation, 27(3), 1070-1075.

Swiger, K. J., Martin, S. S., Blaha, M. J., Toth, P. P., Nasir, K., Michos, E. D., ... & Jones, S. R. (2014). Narrowing sex differences in lipoprotein cholesterol subclasses following mid‐life: the very large database of lipids (VLDL‐10B). Journal of the American Heart Association, 3(2), e000851.

Metelskaya, V. A., Shalnova, S. A., Yarovaya, E. B., Kutsenko, V. A., Boytsov, S. A., Shlyakhto, E. V., & Drapkina, O. M. (2022). Lipoprotein Profile in Populations from Regions of the Russian Federation: ESSE-RF Study. International journal of environmental research and public health, 19(2), 931.

Guetta, V., & Cannon III, R. O. (1996). Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women. Circulation, 93(10), 1928-1937.

Villarreal-Molina, M. T., Aguilar-Salinas, C. A., Rodríguez-Cruz, M., Riaño, D., Villalobos-Comparan, M., Coral-Vazquez, R., & Metabolic Study Group. (2007). The ATP-binding cassette transporter A1 R230C variant affects HDL cholesterol levels and BMI in the Mexican population: association with obesity and obesity-related comorbidities. Diabetes, 56(7), 1881-1887.

Villarreal-Molina, M. T., Flores-Dorantes, M. T., Arellano-Campos, O., Villalobos-Comparan, M., Rodríguez-Cruz, M., Miliar-García, A., & Metabolic Study Group. (2008). Association of the ATP-binding cassette transporter A1 R230C variant with early-onset type 2 diabetes in a Mexican population. Diabetes, 57(2), 509-513.

Nesto, R. W. (2008). LDL cholesterol lowering in type 2 diabetes: what is the optimum approach? Clinical Diabetes, 26(1), 8-13.

Lewis, S. (2017). The effects of obesity on cholesterol levels. Retrived from https://healthguides. healthgrades. Com/howobesity-affects-your’s-health/lower-your’s-weight-lower-your’s-cholesterol.

Hill, W. D., Weiss, A., Liewald, D. C., Davies, G., Porteous, D. J., Hayward, C., & Deary, I. J. (2020). Genetic contributions to two special factors of neuroticism are associated with affluence, higher intelligence, better health, and longer life. Molecular psychiatry, 25(11), 3034-3052.

Yanai, H. (2017). VLDL is the leading actor in lipid abnormality in patients with diabetes and obesity. Journal of Endocrinology and Metabolism, 7(4), 101-102.

Goldberg, I. J. (2001). Diabetic dyslipidemia: causes and consequences. The Journal of Clinical Endocrinology & Metabolism, 86(3), 965-971.